Net income surged to $170.2 million compared to a loss in the prior year.
Adjusted EBITDA margin expanded to 51.4% from 43.4%.
Completed sale of 90% of MIAXdx for a $50.5 million gain.
Acquisition of TISE provides entry into European and UK markets.
The Q1 2026 filing presents a company in a state of aggressive transition, where operational success in the options market is battling against regulatory headwinds and a reliance on one-time gains. On one hand, the growth in options market share and the shift toward positive capture in equities suggest a business that is finding its footing and scaling efficiently. On the other hand, the reliance on a few massive clients and the looming return of Section 31 fees introduce a level of volatility that may offset the operational wins. Ultimately, the investment thesis hinges on whether MIAX can convert its current cash fortress into sustainable, recurring growth across all segments. While the balance sheet provides a significant cushion, the true test will be the company's ability to maintain margins as the temporary regulatory fee holidays end and the CAT funding uncertainty is resolved. Investors are left to weigh the impressive 51.4% adjusted EBITDA margin against the risk that such figures are partially artificial.